Učitavanje...
Rapid test detection of anti-infliximab antibodies: performance comparison with three different immunoassays
Background and Aims: Therapeutic drug monitoring (TDM) of infliximab (IFX) and anti-infliximab antibodies (ATIs) is essential for treatment optimisation in inflammatory bowel disease (IBD) patients. The aim of this study was to estimate and compare the agreement and accuracy between a new rapid test...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publishing
2020-11-01
|
| Serija: | Therapeutic Advances in Gastroenterology |
| Online pristup: | https://doi.org/10.1177/1756284820965790 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Učitavanje...